Storage Tank Market Size to Hit US$ 44.82 Billion by 2032, Driven by Increasing Demand Across Various Industries & Efficient Storage Solutions | Research by SNS Insider
September 27, 2024 08:43 ET
|
SNS Insider pvt ltd
Pune, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Storage Tank Market Report Scope: “According to SNS Insider Research, The Storage Tank Market size was valued at US$ 24.34 billion in 2023 and is...
Burning Rock Announces Changes to Management and Board of Directors
September 27, 2024 08:37 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR) (the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Aquestive Therapeutics Spotlights its Innovative Epinephrine Delivery Pipeline at Virtual Investor Day
September 27, 2024 08:30 ET
|
Aquestive Therapeutics, Inc.
Announces completion of enrollment in its oral allergen challenge study for the development of its late-stage pipeline program, Anaphylm™ (epinephrine) Sublingual FilmOutlines the development strategy...
VCI Global Announces Termination of Its At-the-Market Offering Program
September 27, 2024 08:30 ET
|
VCI Global Limited
KUALA LUMPUR, Malaysia, Sept. 27, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (Frankfurt: H0T) (“VCI Global,” “VCIG,” or the “Company”) today announced the termination of its...
Latin Metals Announces Closing of Private Placement for Gross Proceeds of $2.0 Million
September 27, 2024 08:30 ET
|
Latin Metals Inc.
VANCOUVER, British Columbia, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Latin Metals Inc. (“Latin Metals” or the “Company”) - (TSXV: LMS) (OTCQB: LMSQF) announces that it has closed its previously announced...
TALVEY®▼ (talquetamab) and DARZALEX® (daratumumab) subcutaneous (SC) formulation-based combination shows deep and durable responses in patients with relapsed or refractory multiple myeloma
September 27, 2024 08:21 ET
|
Janssen Cilag International NV
Updated data show 100 percent overall response rate, with 56 percent of patients achieving complete response or better with weekly dosing, supporting the combinability of the GPRC5D bispecific...
Novel combination of TALVEY®▼ (talquetamab) and TECVAYLI®▼ (teclistamab) suggest high response rates and durable responses in triple-class refractory patients with relapsed or refractory multiple myeloma, including those with extramedullary disease
September 27, 2024 08:21 ET
|
Janssen Cilag International NV
Data from the investigational Phase 1b RedirecTT-1 study demonstrate a safety profile consistent to talquetamab and teclistamab monotherapies1 BEERSE, BELGIUM, Sept. 27, 2024 (GLOBE NEWSWIRE) --...
EQV Ventures Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants
September 27, 2024 08:00 ET
|
EQV Ventures Acquisition Corp.
PARK CITY, UT, Sept. 27, 2024 (GLOBE NEWSWIRE) -- EQV Ventures Acquisition Corp. (“EQV” or the “Company”) announced today that, effective immediately, holders of the units sold in the Company’s...
Expanse Studios (GMGI) Ignites Industry Interest With Groundbreaking Games at SBC Summit Lisbon 2024
September 27, 2024 08:00 ET
|
Golden Matrix Group Inc,
iGaming Innovator Reports Discussions With Over 20 Potential Partners, Showcases New Social Casino and Crash Game Offerings LISBON, Portugal, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Expanse Studios, a...
Hurco Celebrates Successful IMTS as Show Generates Excitement Over Technological Advancements
September 27, 2024 08:00 ET
|
Hurco Companies, Inc.
INDIANAPOLIS, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Hurco Companies, Inc. (Nasdaq: HURC) delivered a standout performance at the 2024 International Manufacturing Technology Show (IMTS) in Chicago,...